India’s ageing population is creating a growing need for trained professionals who can provide medical, psychological, social and day-to-day support to senior citizens. As more elderly people require ...
Tavapadon, a treatment for Parkinson’s disease recently approved by the FDA, provides a novel option for healthcare providers ...
AbbVie presents 60 abstracts and presentations from a robust portfolio spanning across alopecia areata, atopic dermatitis, hidradenitis suppurativa, non-segmental vitiligo, psoriasis and psoriatic ...
FDA approves Juvmo (tavapadon), a selective D1/D5 receptor partial agonist, for Parkinson disease based on phase 3 TEMPO trial data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results